Patent application number | Description | Published |
20120303651 | HYBRID AND ITERATIVE KEYWORD AND CATEGORY SEARCH TECHNIQUE - Provided are techniques for providing recommendations to improve a query. A query with query keywords and selected categories is received. In response to determining that the selected categories are ranked high with reference to query relevance indicator values for each of the selected categories, a query relevance indicator of the query is calculated with each subcategory using keyword relevance indicators, each subcategory is ranked based on the query relevance indicators, and the ranked subcategories are provided for use in selecting new categories to be submitted with the query. | 11-29-2012 |
20130191400 | HYBRID AND ITERATIVE KEYWORD AND CATEGORY SEARCH TECHNIQUE - Provided are techniques for providing recommendations to improve a query. A query with query keywords and selected categories is received. In response to determining that the selected categories are ranked high with reference to query relevance indicator values for each of the selected categories, a query relevance indicator of the query is calculated with each subcategory using keyword relevance indicators, each subcategory is ranked based on the query relevance indicators, and the ranked subcategories are provided for use in selecting new categories to be submitted with the query. | 07-25-2013 |
20140108390 | HYBRID AND ITERATIVE KEYWORD AND CATEGORY SEARCH TECHNIQUE - Provided are techniques for providing recommendations to improve a query. A query with query keywords and selected categories is received. In response to determining that the selected categories are ranked high with reference to query relevance indicator values for each of the selected categories, a query relevance indicator of the query is calculated with each subcategory using keyword relevance indicators, each subcategory is ranked based on the query relevance indicators, and the ranked subcategories are provided for use in selecting new categories to be submitted with the query. | 04-17-2014 |
Patent application number | Description | Published |
20110318801 | XYLOSE UTILIZATION IN RECOMBINANT ZYMOMONAS - expressing xylose isomerase from | 12-29-2011 |
20120156746 | XYLOSE UTILIZATION IN RECOMBINANT ZYMOMONAS - Xylose-utilizing | 06-21-2012 |
20130078694 | PANTOTHENIC ACID BIOSYNTHESIS IN ZYMOMONAS - is unable to synthesize pantothenic acid and requires this essential vitamin in growth medium. | 03-28-2013 |
20130157331 | PNP GENE MODIFICATION FOR IMPROVED XYLOSE UTILIZATION IN ZYMOMONAS - The endogenous pnp gene encoding polynucleotide phosphorylase in the | 06-20-2013 |
20130157332 | GENE INACTIVATION ALLOWING IMMEDIATE GROWTH ON XYLOSE MEDIUM BY ENGINEERED ZYMOMONAS - cells that are genetically engineered to have a disrupted aldose reductase gene such that aldose reductase activity for conversion of xylose to xylitol in the presence of NADPH is reduced by greater than 90%, and that are engineered to express a xylose utilization metabolic pathway, were found to have the ability to gro on medium containing xylose as the only sugar without adaptation in media containing xylose. | 06-20-2013 |
20140178954 | EXPRESSION OF XYLOSE ISOMERASE ACTIVITY IN YEAST - Expression of a xylose isomerase in a yeast cell that expresses the chaperonins GroES and GroEL was found to result in enzymatically active xylose isomerase, while there is little to no activity with expression of the bacterial xylose isomerase in a yeast cell lacking GroES and GroEL. A yeast cell expressing xylose isomerase activity, and a complete xylose utilization pathway, provides a yeast cell that can produce a target compound, such as ethanol, butanol, or 1,3-propanediol, using xylose derived from lignocellulosic biomass as a carbon source. | 06-26-2014 |
Patent application number | Description | Published |
20100152196 | Novel Fused Pyrrolocarbazoles - The present invention relates generally to selected fused pyrrolocarbazoles, including pharmaceutical compositions thereof and methods of treating diseases therewith. The present invention is also directed to intermediates and processes for making these fused pyrrolocarbazoles. | 06-17-2010 |
20100273779 | Pyridazinone Derivatives - The present invention is directed to novel pyridizinone derivatives that mediate enzymatic activity. In particular, the compounds may be effective in the treatment of diseases or disease states related to the activity of the histamine H3 receptor, including, for example, neurodegenerative disorders, sleep/wake disorders, attention deficit hyperactivity disorder and cognition. | 10-28-2010 |
20100280007 | Pyridazinone Derivatives - The present invention is directed to novel pyridizinone derivatives that mediate enzymatic activity. In particular, the compounds may be effective in the treatment of diseases or disease states related to the activity of the histamine H3 receptor, including, for example, neurodegenerative disorders, sleep/wake disorders, attention deficit hyperactivity disorder and cognition. | 11-04-2010 |
20110071131 | Substituted Spirocyclic Piperidine Derivatives as Histamine-3 (H3) Receptor Ligands - The present invention provides compounds of Formula (I): | 03-24-2011 |
20110288075 | Pyridazinone Derivatives - The present invention is directed to novel pyridazinone derivatives that mediate enzymatic activity. In particular, the compounds may be effective in the treatment of diseases or disease states related to the activity of the histamine H3 receptor, including, for example, neurodegenerative disorders, sleep/wake disorders, attention deficit hyperactivity disorder and cognition/cognitive disorders. | 11-24-2011 |
20120004253 | Novel Fused Pyrrolocarbazoles - The present invention relates generally to selected fused pyrrolocarbazoles, including pharmaceutical compositions thereof and methods of treating diseases therewith. The present invention is also directed to intermediates and processes for making these fused pyrrolocarbazoles. | 01-05-2012 |
20140113882 | Azaquinazoline Inhibitors of Atypical Protein Kinase C - The present application provides a compound of formula (I) | 04-24-2014 |
20140142088 | PYRIDAZINONE DERIVATIVES - The present invention is directed to novel pyridazinone derivatives that mediate enzymatic activity. In particular, the compounds may be effective in the treatment of diseases or disease states related to the activity of the histamine H3 receptor, including, for example, neurodegenerative disorders, sleep/wake disorders, attention deficit hyperactivity disorder and cognition. | 05-22-2014 |
Patent application number | Description | Published |
20120157500 | JAK INHIBITION BLOCKS RNA INTERFERENCE ASSOCIATED TOXICITIES - The instant invention provides a method for treating patients by administering a JAK inhibitor. The instant invention provides a method for treating patients by administering a JAK inhibitor wherein the JAK inhibitor is a JAK2 inhibitor. The instant invention provides a method for treating patients by administering a JAK inhibitor wherein the JAK inhibitor is selected from selected from Jak2-IA, AG490, Pyridone 6, WP1066, LS104, TG101209, TG101348, CP690,550, CP352,664, INCB18424, WHI-P154, CMP6, SB1518, XL019, CEP-701, INCB20, AUH-6-96 and AZ960. | 06-21-2012 |